Related Experiment Videos
Coronary artery bypass grafting for left ventricular dysfunction
1Civic Hospital, Brescia, Italy.
Insights
Coronary artery bypass grafting improves long-term survival in severe coronary disease patients with poor left ventricular function. It protects heart muscle and can restore function in heart failure patients with viable myocardium.
Area of Science:
- Cardiology
- Cardiac Surgery
- Cardiovascular Research
Background:
- Severe coronary artery disease (CAD) with impaired left ventricular (LV) function presents a significant clinical challenge.
- Coronary artery bypass grafting (CABG) is a cornerstone therapy, but its role in specific patient subsets requires ongoing evaluation.
- Assessing myocardial viability and contractile reserve is crucial for patient selection and optimizing outcomes.
Purpose of the Study:
- To review the impact of coronary artery bypass grafting on long-term survival and functional status in patients with severe coronary disease and poor left ventricular function.
- To delineate the role of CABG in patients with angina, documented ischemia, and heart failure without angina but with viable myocardium.
- To highlight the importance of accurate patient selection and advances in perioperative management for improving outcomes.
Main Methods:
- Review of existing literature and clinical data on coronary artery bypass grafting outcomes.
- Analysis of factors influencing hospital mortality and long-term survival post-CABG.
- Evaluation of methods for assessing myocardial viability and contractile reserve.
- Examination of improvements in left ventricular function following CABG.
Main Results:
- Coronary artery bypass grafting demonstrates a positive impact on long-term survival in patients with severe CAD and poor LV function.
- CABG is beneficial in protecting viable myocardium from infarction in patients with angina or ischemia.
- In heart failure patients with akinetic but viable myocardium, CABG can lead to recovery of myocardial function.
Conclusions:
- Coronary artery bypass grafting is a valuable treatment option for selected patients with ischemic cardiomyopathy, improving survival and cardiac function.
- Accurate preoperative assessment of myocardial viability and contractile reserve is essential for successful patient selection.
- Advances in perioperative care and refined selection criteria have significantly improved the safety and efficacy of CABG.
Abstract:
In patients with severe coronary disease and poor left ventricular function, coronary artery bypass grafting has a positive impact on long-term survival. In presence of angina or documented ischemia, it is beneficial in protecting functioning muscle against future infarction. In patients with heart failure and no angina, it is a rational option when large areas of akinetic but viable myocardium are identified preoperatively; under these circumstances, recovery of myocardial function is the goal of coronary revascularization. Obviously, reliable methods of assessing myocardial viability and contractile reserve are required for an accurate selection of patients. Advances in perioperative management, including myocardial preservation, have consistently reduced the operative risk in the most recent series, and more appropriate selection criteria have substantially contributed to the improved long-term survival. Variables associated with higher hospital mortality as well as factors influencing long-term outcome have been identified. The beneficial effect of coronary artery bypass grafting on the functional status of patients has been documented in several studies, and the improvement in left ventricular function has been objectively demonstrated. The concepts and the data presented in this review may help to define the present role of coronary artery bypass grafting in the treatment of ischemic cardiomyopathy.